About me
Dr. Garner is executive leader for Global Regulatory Affairs for Eli Lilly and Company. The organization is responsible for the regulatory leadership, strategic and operational support for human drugs, medical devices, and global manufacturing for Eli Lilly and Company. Additionally, Dr Garner leads Lilly's Regenerative Medicine business responsible of the development and commercialization of gene therapies to treat rare and sensory diseases. Dr. Garner and his teams lead Lilly’s external engagements with global regulatory authorities, regenerative medicines key opinion leaders, and other stakeholders to share the goal of improving public health by creating medicines that make life better for people around the world.
